UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives.
Ontology highlight
ABSTRACT: The number of patients with urothelial carcinoma (UC) is high, with a corresponding demand for detecting UC easily and non-invasively. Cystoscopy and urine cytology, with widely known diagnostic accuracies, are the gold standards for identifying UC originating from the bladder. However, cystoscopy or other tests, such as ureteroscopy or retrograde pyelography, are uncomfortable for patients. Tests for urinary biomarkers are expected to satisfy the demand for less invasive tests that will benefit patients with anxiety for invasive tests such as cystoscopy or ureteroscopy. Although several urinary biomarkers have been reported to support the diagnosis or follow-up of UC, their use in the clinic is uncommon. The UroVysion test examines urinary biomarkers using a multitarget, multicolor fluore
SUBMITTER: Nagai T
PROVIDER: S-EPMC8100858 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA